Literature DB >> 4542253

Complement-dependent release of immune complexes from the lymphocyte membrane.

G W Miller, P H Saluk, V Nussenzweig.   

Abstract

Soluble antigen-antibody-complement complexes bound to mouse B lymphocytes are rapidly released from the cell membrane in the presence of normal serum from several mammalian species. The release is not the result of antigen-antibody dissociation or extensive degradation of the complexes. However, the released complexes have been altered because they will no longer bind to fresh lymphocytes. The release is not the result of lymphocyte damage mediated by complement. It is complement-dependent, and is generated either preferentially or exclusively via the alternate pathway, since it occurs in C4-deficient serum, is Mg(++) but not Ca(++) dependent, and requires C3 proactivator. C3 inactivator is not involved. The release activity of the serum, once generated, is unstable at 37 degrees C. The release of complexes from the lymphocyte membrane by serum provides a convenient assay for the functioning of the alternate pathway in the mouse and in other species.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4542253      PMCID: PMC2139414          DOI: 10.1084/jem.138.3.495

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

1.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

2.  Interaction and release of soulble immune complexes from mouse B luymphocytes.

Authors:  A Eden; C Bianco; B Bogart; V Nussenzweig
Journal:  Cell Immunol       Date:  1973-06       Impact factor: 4.868

3.  A receptor for Fc on mouse B-lymphocytes.

Authors:  F Paraskevas; S T Lee; K B Orr; L G Israels
Journal:  J Immunol       Date:  1972-05       Impact factor: 5.422

Review 4.  Immunologic mechanisms of platelet damage.

Authors:  A G Osler; R P Siraganian
Journal:  Prog Allergy       Date:  1972

5.  The biologic activities of guinea pig antibodies. II. Modes of complement interaction with gamma 1 and gamma 2-immunoglobulins.

Authors:  A L Sandberg; A G Osler; H S Shin; B Oliveira
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

6.  Inhibitor of human C3 associated with preparations of C3 dissociated from C3-zymosan complex.

Authors:  L Blum
Journal:  J Immunol       Date:  1969-11       Impact factor: 5.422

7.  C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.

Authors:  S Ruddy; K F Austen
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

8.  Immunological induction of increased vascular permeability. II. Two mechanisms of histamine release from rabbit platelets involving complement.

Authors:  P M Henson; C G Cochrane
Journal:  J Exp Med       Date:  1969-01-01       Impact factor: 14.307

9.  A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization.

Authors:  C Bianco; R Patrick; V Nussenzweig
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

10.  Serum-dependent phagocytosis of paraffin oil emulsified with bacterial lipopolysaccharide.

Authors:  T P Stossel; C A Alper; F S Rosen
Journal:  J Exp Med       Date:  1973-03-01       Impact factor: 14.307

View more
  26 in total

1.  Rat spleen leucocyte (RSL) radioimmunoassay for the detection and quantification of soluble immune complexes.

Authors:  S F Al-Khateeb; T Barkas
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

2.  Serum factors influencing antibody-directed cell-mediated cytotoxicity (ADCC) and their effects on the detection of immune complexes by inhibition of ADCC.

Authors:  T Barkas; S F Al-Khateeb
Journal:  Immunology       Date:  1979-02       Impact factor: 7.397

3.  Prolonged circulation of immune complexes due to various altered immune functions contributes to nephritis in MRL/lpr mice.

Authors:  N A Granholm; T Cavallo
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

4.  A new complement function: solubilization of antigen-antibody aggregates.

Authors:  G W Miller; V Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

5.  Lipopolysaccharide from gram-negative bacteria enhances polyclonal B cell activation and exacerbates nephritis in MRL/lpr mice.

Authors:  T Cavallo; N A Granholm
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

6.  Interaction of complement solubilized complexes with mouse peritoneal macrophages and their clearance and tissue uptake.

Authors:  N Takahashi; T Fujita; Y Takata; N Tamura
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

7.  Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.

Authors:  R M Des Prez; C S Bryan; J Hawiger; D G Colley
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

8.  Reversal of immune complex inhibition of antibody-dependent cell-mediated cytotoxicity by normal human serum.

Authors:  M A Isturiz; S B Fink; M M de Bracco
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

9.  Demonstration of IgG Fc receptors on spermatozoa and their utilization for the detection of circulating immune complexes in human serum.

Authors:  S S Witkin; S K Shahani; S Gupta; R A Good; N K Day
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

10.  Alternative pathway-mediated rebinding of immune complexes to human red blood cells.

Authors:  M E Medof; G M Prince
Journal:  Immunology       Date:  1983-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.